GANGLIOGLIOMA (WHO I) GANGLIOGLIOMA (WHO I)
Transcription
GANGLIOGLIOMA (WHO I) GANGLIOGLIOMA (WHO I)
NON--GLIAL PEDIATRIC BRAIN NON TUMORS Arie Perry, M.D. GANGLIOGLIOMA (WHO I) Children/young adults Chronic seizure disorder Temporal lobe Benign/surgically curable Anaplastic variant rare: ?definition – WHO grade III (grade II eliminated in 2007) Genetics inconsistent GANGLIOGLIOMA (WHO I) EMBRYONAL/NEURONAL NEOPLASMS Ganglio = large mature neuron Neurocyte = small mature neuron Neuroblast = small primitive neuron Paraganglio P li = autonomic t i neuroendocrine cell Esthesio = olfactory neuronal cell Pineo = pineal neuronal cell Retino = retinal neuronal cell GANGLIOGLIOMA (WHO I) PASD CG SYN DESMOPLASTIC INFANTILE GANGLIOGLIOMA (DIG) (WHO I) Age <2 years Massive cystic/solid hemispheric mass Dural attachment common Small glioneuronal cells in a fibrous histiocytoma-like background PNET-like foci Favorable prognosis CD34 DIG, WHO I CENTRAL NEUROCYTOMA (WHO II) Older children/Young adults Lat. v./3rd v./F. of Monro/S. pellucidum Obstructive hydrocephalus Globular/calcified Usually benign, but may recur (MIB-1>2%) DDx: oligodendroglioma, ependymoma Genetics inconsistent, but no 1p/19q losses GFAP SYN Neu-N Reticulin CENTRAL NEUROCYTOMA, WHO II SYN Neu-N GFAP MIB-1 EXTRAVENTRICULAR NEUROCYTOMAS PINEAL PARENCHYMAL TUMORS Pineocytoma, WHO grade I PPT, Int. Differentiation, WHO grades II or III PINEOCYTOMA, WHO GRADE I – Identical to neurocytomas (pineocytic rosettes) – No rosettes, mitotic activity, NF+ = gr. II – High MI (Ki-67) and no NF+ = gr. III Pineoblastoma, WHO grade IV PPT, INT. DIFF., WHO GRADE II or III PINEOBLASTOMA, WHO GRADE IV GERM CELL TUMORS GERMINOMA Children/young adults Pineal gland (boys)/suprasellar (both sexes) Parinaud’s syndrome (upward gaze paralysis) Precocious P i puberty b Germinoma radiosensitive Teratoma resectable Other germ cell elements = worse prognosis CD117 MEDULLOBLASTOMA/PNET (WHO IV) EMBRYONAL CNS TUMORS Medulloblastoma – – – – – Classic Desmoplastic Extensively Nodular L Large cell/Anaplastic ll/A l ti Medullo with myogenic differentiation – Medullo with melanotic differentiation Pineoblastoma CNS PNET – – – – Neuroblastoma Ganglioneuroblastoma Ependymoblastoma Medulloepithelioma Atypical teratoid / Rhabdoid tumor OCT 3/4 Children/young adults Aggressive natural history CSF seeding (“icing” and drop mets) 55-year year survival: 60 60-80% 80% with therapy Radiation may save patient’s life, but is harmful to the developing CNS Favorable and unfavorable variants Histogenesis: EGL or SEGM of 4th ventricle